I agree forbes etc - The announcement was designed to supress positives: 1.institutional buyers will not take long to figure out that increased royalties have already started with initial production increase to 60mill doses - which in itself was a major milestone - the impression pc gave was that there wouldn't be any major extra royalties hitting BTA's books for another year (this will only affect mums and dads) 2 there are quite a few million shares now out of short term players hands (past couple weeks) 3 every major newspaper in the world is running the rlenza story in the business section- and many who havn't looked into biota - now will 4. The lani story will be told soon and - and build upon the relenza story - except biota will be the centre piece instaed of gsk 5. commentators will race with there little pens to be the first to point out how cashed up BTA (the cash cow) is while the rest of the western worlds blue chips are going backwards -(wow what a find) 6. Kevin Rudd will proadly announce that biota is an AUSTRALIAN co on the international stage
all these inevitable things will come to pass - it will be interseting to sit back and see the belated kick in as the penny drops.....
may even start this arvo for the real smart institutional buyers
7. this has been a lot of fun - congrats to all - i don't think we really need to do anything - a roll has started which can't be stopped - once the many get a whiff of easy cash
BTA Price at posting:
$1.77 Sentiment: LT Buy Disclosure: Held